Market Research Logo

Luminex Corporation (LMNX) - Financial and Strategic SWOT Analysis Review

Luminex Corporation (LMNX) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Luminex Corporation (Luminex) is a medical devices company that carries out the development, manufacturing and marketing of proprietary biological testing technologies. The company offers wide range of products that include instruments, assays, reagents and accessories, software and replacement parts. Its proprietary technologies consist of xMAP technology, xTAG and MultiCode technology. Luminex offers its products to various markets such as clinical diagnostics; pharmaceutical drug discovery; biomedical research including personalized medicine, genomic and proteomic research, biodefense research and food safety. It also provides support and training services for its products. The company has operations in North America, Europe and Asia-Pacific th. Luminex is headquartered in Texas, the US.


Luminex Corporation Key Recent Developments
Feb 01, 2016: Luminex Reports Fourth Quarter And Full Year 2015 Results
Nov 02, 2015: Luminex Reports 3rd Quarter 2015 Results
Aug 03, 2015: Luminex Reports Record 2nd Quarter 2015 Results
Jul 22, 2015: Atossa Genetics Subsidiary The NRLBH Now Provides Enhanced Pharmacogenetic Test Based on Luminex xTAG Platform
Jul 06, 2015: Enzo Biochem Reaches $7.1 Million Patent Infringement Settlement with Luminex

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Luminex Corporation - Key Facts
Luminex Corporation - Key Employees
Luminex Corporation - Key Employee Biographies
Luminex Corporation - Major Products and Services
Luminex Corporation - Medical Equipment Pipeline Products Data
Luminex Corporation Pipeline Products by Equipment Type
Luminex Corporation Pipeline Products by Development Stage
Luminex Corporation - History
Luminex Corporation - Company Statement
Luminex Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Luminex Corporation - Key Manufacturing Facilities
Section 2 – Company Analysis
Luminex Corporation - Business Description
Luminex Corporation - Corporate Strategy
Luminex Corporation - SWOT Analysis
SWOT Analysis - Overview
Luminex Corporation - Strengths
Strength - Proprietary Technologies
Strength - Assay Products
Strength - High Liquidity
Luminex Corporation - Weaknesses
Weakness - Declining performance of Consumable Category
Weakness - Patent Infringement Concerns
Luminex Corporation - Opportunities
Opportunity - Growing IVD Market
Opportunity - Regulatory Approvals
Opportunity - Strategic Partnerships
Luminex Corporation - Threats
Threat - Stiff Competition
Threat - Stringent Regulations
Threat - Rapid Technology Changes
Luminex Corporation - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Luminex Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
Luminex Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
Luminex Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Luminex Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Luminex Corporation, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 21, 2016: Luminex Receives CE-IVD Mark for ARIES System
Mar 21, 2016: Luminex Receives CE-IVD Mark for ARIES HSV 1&2 Assay
Feb 22, 2016: Luminex Receives Medical Device License for ARIES System in Canada
Feb 22, 2016: Luminex Receives Medical Device License for ARIES HSV 1&2 Assay in Canada
Feb 01, 2016: Luminex Reports Fourth Quarter And Full Year 2015 Results
Dec 18, 2015: Luminex Receives FDA Clearance for NxTAG Respiratory Pathogen Panel
Nov 02, 2015: Luminex Reports 3rd Quarter 2015 Results
Aug 26, 2015: Luminex Seeks FDA Approval For NxTAG Respiratory Pathogen Panel
Aug 03, 2015: Luminex Reports Record 2nd Quarter 2015 Results
Jul 22, 2015: Atossa Genetics Subsidiary The NRLBH Now Provides Enhanced Pharmacogenetic Test Based on Luminex xTAG Platform
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Luminex Corporation, Key Facts
Luminex Corporation, Key Employees
Luminex Corporation, Key Employee Biographies
Luminex Corporation, Major Products and Services
Luminex Corporation Number of Pipeline Products by Equipment Type
Luminex Corporation Pipeline Products by Equipment Type
Luminex Corporation Number of Pipeline Products by Development Stage
Luminex Corporation Pipeline Products by Development Stage
Luminex Corporation, History
Luminex Corporation, Other Locations
Luminex Corporation, Subsidiaries
Luminex Corporation, Key Manufacturing Facilities
Luminex Corporation, Key Competitors
Luminex Corporation, Ratios based on current share price
Luminex Corporation, Annual Ratios
Luminex Corporation, Interim Ratios
Luminex Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
Luminex Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
Luminex Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Luminex Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Luminex Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Luminex Corporation Pipeline Products by Equipment Type
Luminex Corporation Pipeline Products by Development Stage
Luminex Corporation, Performance Chart (2011 - 2015)
Luminex Corporation, Ratio Charts
Luminex Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
Luminex Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016
Luminex Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Luminex Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report